Komori
Occurring Fact4568DAIICHI SANKYO COMPANY,LIMITEDPharmaceuticals

Notice Regarding the Execution of a Loan Agreement with Financial Covenants

DAIICHI SANKYO COMPANY,LIMITED entered into a ¥200 billion loan agreement with a syndicate of city and regional banks to secure long-term working capital. The agreement includes financial covenants relating to consolidated and non-consolidated net assets and earnings.

Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
2000
¥100 million
Wording
Definitive
How definitive the wording is.

Execution of a Loan Agreement Containing Financial Covenants

Subject Entity

DAIICHI SANKYO COMPANY,LIMITED (filing company)

Occurrence17 June 2026 (date of agreement execution)
This disclosure06/17/2026
Cause

To secure long-term working capital

Accounting period in which recognized

Fiscal year ending March 2027 (impact on results)

Impact on Earnings Forecast

The impact of executing this agreement on results for the fiscal year ending March 2027 is immaterial.

Outlook

The impact of executing this agreement on results for the fiscal year ending March 2027 is immaterial.

Event that occurred
ItemDetails
Event nameExecution of a Loan Agreement Containing Financial Covenants
Date of occurrence17 June 2026 (date of agreement execution)
Subject EntityDAIICHI SANKYO COMPANY,LIMITED (filing company)
CauseTo secure long-term working capital
Accounting period in which recognizedFiscal year ending March 2027 (impact on results)
Impact on Earnings ForecastThe impact of executing this agreement on results for the fiscal year ending March 2027 is immaterial.
OutlookThe impact of executing this agreement on results for the fiscal year ending March 2027 is immaterial.
Items this document does not state (18)
Date recognized / date notice receivedTarget Locations / ProductsAmount of Impact on Business PerformanceType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To secure long-term working capital

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Execution of a Loan Agreement with Financial Covenants | DAIICHI SANKYO COMPANY,LIMITED (4568) timely disclosure | Komori